Loading patent…
AssigneeShanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicin
InventorsXiang GU, Shiqiong Xu, Xianqun Fan, Renbing Jia, Ziyue Huang, Hao Tian
Estimating the term…
A human sebaceous gland carcinoma cell line and use thereof are provided. The human sebaceous gland carcinoma cell line SHNPH-SeC was deposited in the China Center for Type Culture Collection (CCTCC) on Aug. 31, 2023, with an accession number CCTCC NO: C2023113. The human sebaceous gland carcinoma cell line SHNPH-SeC carries a TP53 mutation, and has been identified as a novel single cell line by short tandem repeat (STR) genotyping. This human sebaceous gland carcinoma cell line exhibits strong adherence and stable cellular characteristics, can be stably passaged for multiple generations, and possesses rapid proliferation and migration capabilities, which are in line with the characteristics of malignant tumor cells.
A human sebaceous gland carcinoma cell line, wherein the human sebaceous gland carcinoma cell line was deposited in the China Center for Type Culture Collection (CCTCC) on Aug. 31, 2023, with an accession number CCTCC NO:
Dependencies are inferred from the claim text.